Almac Clinical Technologies Celebrates Successful Launch of Drug Reconciliation Tool
September 5, 2006
Thursday 24 August 2006, Almac Clinical Technologies, formerly known as ICTI, announces the successful launch of Almac Drug Reconciliation, a key component of the Almac total drug supply management solution. Using Almac Drug Reconciliation, it is now possible for the full lifecycle of study medication to be tracked and managed from one 21 CFR compliant database including each step from release to destruction.
User feedback has indicated that Almac Drug Reconciliation has dramatically reduced the amount of time and effort spent by monitors and depot personnel managing the drug return and reconciliation process. Almac Drug Reconciliation achieves this increased efficiency by making key drug tracking information from the IXRS™ (interactive voice and web response system) database available to monitors and depot personnel through a flexible and intuitive bi-layered web interface. The interface is configurable and can be tailored to support any distinct drug return process. Additionally, the interface greatly streamlines the process of isolating target kits by allowing users to sort and filter based on any data field. Lastly, Almac Drug Reconciliation generates user-friendly reports that can be printed for permanent record.
Jamie Romanowski, Technical Manager of New Products and Services, comments
“With the completion of this project, we have successfully established a comprehensive solution for tracking our client’s drug through the full drug lifecycle. This is a key step in our efforts to establish the most complete and seamless integrated drug supply management solution in the industry.”
Almac Clinical Technologies, formerly ICTI, is a division of Almac that specializes in interactive technology and service solutions to increase the quality and efficiency of the clinical trial process. Our solutions include Interactive Voice and Web Response Systems (IXRS™) for patient randomization, tracking and clinical supply management, iDiary for phone-based electronic patient reported outcome data collection, and iTrial EDC for electronic case report form data collection.
Almac and its affiliated companies (Almac Diagnostic Services, Almac Sciences, Almac Clinical Services, Almac Clinical Technologies and Almac Pharma Services) provide a broad range of services across drug discovery, diagnostics, pharmaceutical research and development, manufacture of API, clinical trials and drug product manufacture. US operations are based in Pennsylvania, North Carolina and California. European operations are headquartered in Craigavon, Northern Ireland with additional operations in London and Edinburgh.
Contact: Meghan Adams US: 267-685-4284 / [email protected]